Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis | Zendy

Anna M. Sawka | Zendy; Lehana Thabane | Zendy; Luciana Parlea | Zendy; Irada Ibrahim-zada | Zendy; Richard Tsang | Zendy; James D. Brierley | Zendy; Sharon E. Straus | Zendy; Shereen Ezzat | Zendy; David P. Goldstein | Zendy

Open Access

Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis

Author(s) -

Anna M. Sawka,

Lehana Thabane,

Luciana Parlea,

Irada Ibrahim-zada,

Richard Tsang,

James D. Brierley,

Sharon E. Straus,

Shereen Ezzat,

David P. Goldstein

Publication year - 2009

Publication title -

thyroid

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.918

H-Index - 142

eISSN - 1557-9077

pISSN - 1050-7256

DOI - 10.1089/thy.2008.0392

Subject(s) - medicine , thyroid cancer , relative risk , meta analysis , confidence interval , cancer , oncology , thyroid , incidence (geometry) , physics , optics

The risk of second primary malignancies (SPMs) associated with cancer therapies is an important concern of thyroid cancer survivors and physicians. Our objective was to determine if the risk of SPMs is increased in individuals with thyroid cancer treated with radioactive iodine (RAI), compared to those not treated with RAI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research